KCM
PHAR

Knoll Capital Management’s Pharming Group PHAR Stock Holding History

Knoll Capital Management’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.8K Buy
4,091
+34
+0.8% +$492 0.03% 36
2026
Q1 		$67.5K Buy
+4,057
New +$68.8K 0.04% 35

Other funds holding PHAR

MACM
MAC Alpha Capital Management Tampa, Florida $216M AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Knoll Capital Management's PHAR Position: Q2 2026 in Review

Knoll Capital Management increased its Pharming Group (PHAR) stake by 0.84% in Q2 2026, buying an estimated $492 and bringing the position to 4,091 shares worth $56.8K. The position accounts for 0.03% of the portfolio, ranked #36.

Knoll Capital Management first reported a position in PHAR in Q1 2026 and has held it in 2 quarters since. The position peaked at $67.5K in Q1 2026. 17 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • Knoll Capital Management held 4,091 shares of Pharming Group worth $56.8K as of Q2 2026.
  • Knoll Capital Management bought 34 Pharming Group shares in Q2 2026, an estimated $492.
  • Pharming Group made up 0.03% of Knoll Capital Management's portfolio in Q2 2026, its #36 holding.
  • Knoll Capital Management first reported a position in Pharming Group in Q1 2026 and has held it in 2 quarters since.
  • Knoll Capital Management's Pharming Group position peaked at $67.5K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on Knoll Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.